Form 4: Eastman Chemical Co. Executive Brad A. Lich Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
EVP & CCO of Eastman Chemical Co., Brad A. Lich, reports the acquisition of stock options and restricted stock units.
Summary
- On February 20, 2025, Brad A. Lich, EVP & CCO of Eastman Chemical Co., acquired 32,968 employee stock options with an exercise price of $100.56.
- These options vest in three equal installments beginning February 20, 2026, and continuing on February 20, 2027, and February 20, 2028, with final expiration on February 19, 2035.
- Lich also acquired 6,296 restricted stock units (RSUs) which represent a contingent right to receive one share of Eastman Chemical Co. common stock each.
- These RSUs will vest and payout in unrestricted shares on February 20, 2028, subject to continued employment.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, aligning management interests with shareholders through equity-based incentives.
Positives
- The acquisition of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedules incentivize long-term performance and continued employment.
Risks
- The value of the stock options is dependent on the future performance of Eastman Chemical Co.'s stock price.
- The restricted stock units are subject to forfeiture if the executive's employment is terminated before the vesting date.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of stock options and RSUs incentivizes the executive to contribute to the company's long-term success.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the alignment of management's interests with shareholders. The acquisition of stock options and RSUs is a common practice in the industry to incentivize executives.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices for executives in publicly traded companies like Eastman Chemical.
- Companies such as Dow, BASF, and LyondellBasell also utilize similar equity-based compensation to align executive incentives with shareholder value.
- The vesting schedules and exercise prices are generally in line with industry norms for similar roles and company sizes.
Stakeholder Impact
- Shareholders: The acquisition of stock options and RSUs aligns the executive's interests with those of the shareholders, potentially leading to increased shareholder value.
- Employees: The executive's incentivization may lead to improved company performance, benefiting employees.
- Executive: The executive is incentivized to improve company performance to increase the value of their stock options and RSUs.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of transaction: Acquisition of stock options and restricted stock units. |
| 02/20/2026 | First vesting date for one-third of the stock options. |
| 02/20/2027 | Second vesting date for one-third of the stock options. |
| 02/20/2028 | Final vesting date for one-third of the stock options and vesting date for the restricted stock units. |
| 02/19/2035 | Expiration date of the stock options. |
| 02/24/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.